Patient Experiences With GLP-1 Receptor Agonists - Takeaways - MDSpire

Patient Experiences With GLP-1 Receptor Agonists

  • By

  • Isabella de Vere Hunt

  • Mariana Ramirez-Posada

  • Christopher Sam Babu

  • Cati Brown-Johnson

  • Eleni Linos

  • Fatima Rodriguez

  • June 5, 2026

  • 0 min

Share

  • 1

    GLP-1 receptor agonists are effective for weight reduction and glycemic control, impacting metabolic pathways and appetite regulation.

  • 2

    Obesity is a complex disease linked to various health challenges, including type 2 diabetes and cardiovascular disease.

  • 3

    Challenges of GLP-1 RA therapy include cost, access barriers, variable efficacy, and potential adverse effects, leading to high discontinuation rates.

  • 4

    The qualitative study involved interviews with 30 participants to explore their experiences with GLP-1 RAs across diverse health contexts.

  • 5

    Eight key themes emerged from the analysis, highlighting patient-reported benefits and trade-offs associated with GLP-1 RA use.

Original Source(s)

Patient Experiences With GLP-1 Receptor Agonists

  • by Isabella de Vere Hunt, Mariana Ramirez-Posada, Christopher Sam Babu, Cati Brown-Johnson, Eleni Linos, Fatima Rodriguez

  • June 5, 2026

Related Content

Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Global Trends and Research Topics in Gastric Bypass Clinical Trials: A Bibliometric Analysis and Latent Dirichlet Allocation (LDA) Study